Aimed at regaining compliance with Nasdaq's minimum bid price listing requirement, aTyr Pharma (NASDAQ:LIFE) will execute a 1:14 reverse split of its common stock after the close today.
Post-split trading will commence on Monday, July 1.
Shares are off 4% after hours.